Introduction to Neurocircuitry and Neurobiology of Anxiety
Archives of Advances in Biosciences,
Vol. 12 No. 1 (2021),
23 February 2021
,
Page 45-51
https://doi.org/10.22037/aab.v12i1.25279
Abstract
Context: Nowadays, experiencing occasional anxiety is a common part of each person’s life. The number of anxious people has increased in this modern life style. This study aimed to review some researches as to accelerate searching for new anxiolytic treatments.
Evidence Acquisition: Related articles were extracted from databases including PubMed, Google Scholar, Springer, Science Direct and Wiley. Forty-eight articles were chosen. The articles were carefully considered, and after extracting information, they were categorized and integrated in the appropriate sequences to meet the needs of this study.
Results: This review mentions the important brain regions involved in anxiety; it then continues with encapsulating some of the neurotransmitters’ and neuropeptides’ functions that cope with anxiety-like behaviors.
Conclusion: With regard to the results, it is suggested that anxiety can be caused by change in the brains’ neurotransmitters level but more studies are needed to identify its exact mechanism.
- Anxiety
- Neurotransmitter
- Organelle
- Neurobiology
- Neurocircuitry
How to Cite
References
Zarrindast MR, Mahboobi S, Sadat-Shirazi MS, Ahmadi S. Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems. J Psychopharmacol. 2011;25(1):131-40.
Khalifeh S, Oryan S, Khodagholi F, Digaleh H, Shaerzadeh F, Maghsoudi N, et al. Complexity of Compensatory Effects in Nrf1 Knockdown: Linking Undeveloped Anxiety-Like Behavior to Prevented Mitochondrial Dysfunction and Oxidative Stress. Cell Mol Neurobiol. 2016;36(4):553-63.
Spector AZ. Fatherhood and depression: a review of risks, effects, and clinical application. Issues Ment Health Nurs. 2006;27(8):867-83.
Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009;2(2):63-7.
Kielian T. Lysosomal storage disorders: Pathology within the lysosome and beyond. J Neurochem. 2019.
Jangra A, Sriram CS, Dwivedi S, Gurjar SS, Hussain MI, Borah P, et al. Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation. Cell Mol Neurobiol. 2017;37(1):65-81.
Valizadegan F, Oryan S, Nasehi M, Zarrindast MR. Interaction between morphine and noradrenergic system of basolateral amygdala on anxiety and memory in the elevated plus-maze test based on a test-retest paradigm. Arch Iran Med. 2013;16(5):281-7.
Kuerbitz J, Arnett M, Ehrman S, Williams MT, Vorhees CV, Fisher SE, et al. Loss of Intercalated Cells (ITCs) in the Mouse Amygdala of Tshz1 Mutants Correlates with Fear, Depression, and Social Interaction Phenotypes. J Neurosci. 2018;38(5):1160-77.
Khalifeh S, Oryan S, Digaleh H, Shaerzadeh F, Khodagholi F, Maghsoudi N, et al. Involvement of Nrf2 in development of anxiety-like behavior by linking Bcl2 to oxidative phosphorylation: estimation in rat hippocampus, amygdala, and prefrontal cortex. J Mol Neurosci. 2015;55(2):492-9.
Motevasseli T, Rezayof A, Zarrindast MR, Nayer-Nouri T. Role of ventral hippocampal NMDA receptors in anxiolytic-like effect of morphine. Physiol Behav. 2010;101(5):608-13.
Manteghi F, Nasehi M, Zarrindast MR. Precondition of right frontal region with anodal tDCS can restore the fear memory impairment induced by ACPA in male mice. EXCLI J. 2017;16:1-13.
Navarro JF, Luna G, Garcia F, Pedraza C. Effects of L-741,741, a selective dopamine receptor antagonist, on anxiety tested in the elevated plus-maze in mice. Methods Find Exp Clin Pharmacol. 2003;25(1):45-7.
Pinto A, Sesack SR. Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors. Brain Struct Funct. 2008;213(1-2):159-75.
Sun F, Lei Y, You J, Li C, Sun L, Garza J, et al. Adiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1. Mol Psychiatry. 2018.
Sepehrizadeh Z, Sahebgharani M, Ahmadi S, Shapourabadi MB, Bozchlou SH, Zarrindast MR. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala. Pharmacology. 2008;81(4):333-43.
Levita L, Hoskin R, Champi S. Avoidance of harm and anxiety: a role for the nucleus accumbens. Neuroimage. 2012;62(1):189-98.
Sardari M, Rezayof A, Zarrindast MR. 5-HT1A receptor blockade targeting the basolateral amygdala improved stress-induced impairment of memory consolidation and retrieval in rats. Neuroscience. 2015;300:609-18.
Zarrindast MR, Nasehi M, Pournaghshband M, Yekta BG. Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses. Pharmacol Biochem Behav. 2012;103(1):102-10.
Vousooghi N, Sadat-Shirazi MS, Safavi P, Zeraati R, Akbarabadi A, Makki SM, et al. Adult rat morphine exposure changes morphine preference, anxiety, and the brain expression of dopamine receptors in male offspring. Int J Dev Neurosci. 2018;69:49-59.
Hajizadeh Moghaddam A, Roohbakhsh A, Rostami P, Heidary-Davishani A, Zarrindast MR. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors. Pharmacology. 2008;82(1):59-66.
Piri M, Nasehi M, Asgariyan M, Zarrindast MR. Influence of nitric oxide agents in the dorsal hippocampus of mice on anxiogenic-like effect induced by histamine. Pharmacol Biochem Behav. 2012;102(3):391-9.
Lisboa SF, Borges AA, Nejo P, Fassini A, Guimaraes FS, Resstel LB. Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence. Prog Neuropsychopharmacol Biol Psychiatry. 2015;59:76-83.
Zarrindast MR, Meshkani J, Rezayof A, Beigzadeh R, Rostami P. Nicotinic acetylcholine receptors of the dorsal hippocampus and the basolateral amygdala are involved in ethanol-induced conditioned place preference. Neuroscience. 2010;168(2):505-13.
Rezayof A, Khajehpour L, Zarrindast MR. The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors. Neuroscience. 2009;160(2):255-63.
Bashiri H, Rezayof A, Sahebgharani M, Tavangar SM, Zarrindast MR. Modulatory effects of the basolateral amygdala alpha2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze. Neuropharmacology. 2016;105:478-86.
Keller RF, Dragomir A, Yantao F, Akay YM, Akay M. Investigating the genetic profile of dopaminergic neurons in the VTA in response to perinatal nicotine exposure using mRNA-miRNA analyses. Sci Rep. 2018;8(1):13769.
Zarrindast MR, Tajik R, Ebrahimi-Ghiri M, Nasehi M, Rezayof A. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine. Physiol Behav. 2013;119:103-9.
Young SN. How to increase serotonin in the human brain without drugs. J Psychiatry Neurosci. 2007;32(6):394-9.
Zarrindast MR, Honardar Z, Sanea F, Owji AA. SKF 38393 and SCH 23390 inhibit reuptake of serotonin by rat hypothalamic synaptosomes. Pharmacology. 2011;87(1-2):85-9.
Hedner T, Edgar B, Edvinsson L, Hedner J, Persson B, Pettersson A. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol. 1992;43(6):651-6.
Smits JA, Rosenfield D, Davis ML, Julian K, Handelsman PR, Otto MW, et al. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial. Biol Psychiatry. 2014;75(11):840-6.
Talati A, Odgerel Z, Wickramaratne PJ, Norcini-Pala A, Skipper JL, Gingrich JA, et al. Associations between serotonin transporter and behavioral traits and diagnoses related to anxiety. Psychiatry Res. 2017;253:211-9.
Zarrabian S, Farahizadeh M, Nasehi M, Zarrindast MR. The role of CA3 GABAA receptors on anxiolytic-like behaviors and avoidance memory deficit induced by NMDA receptor antagonists. J Psychopharmacol. 2016;30(2):215-23.
Farahmandfar M, Karimian SM, Zarrindast MR, Kadivar M, Afrouzi H, Naghdi N. Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via mu-opioid receptor. Neurosci Lett. 2011;494(2):130-4.
Rezvanfard M, Zarrindast MR, Bina P. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. Pharmacology. 2009;84(6):356-66.
Perez DM, Papay RS, Shi T. alpha1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Mol Pharmacol. 2009;76(1):144-52.
Zarrindast MR, Homayoun H, Babaie A, Etminani A, Gharib B. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol. 2000;407(1-2):145-58.
Nasehi M, Soltanpour R, Ebrahimi-Ghiri M, Zarrabian S, Zarrindast MR. Interference effects of transcranial direct current stimulation over the right frontal cortex and adrenergic system on conditioned fear. Psychopharmacology (Berl). 2017;234(22):3407-16.
Cain CK, Blouin AM, Barad M. Adrenergic transmission facilitates extinction of conditional fear in mice. Learn Mem. 2004;11(2):179-87.
Piri M, Ayazi E, Zarrindast MR. Involvement of the dorsal hippocampal dopamine D2 receptors in histamine-induced anxiogenic-like effects in mice. Neurosci Lett. 2013;550:139-44.
Roohbakhsh A, Moghaddam AH, Massoudi R, Zarrindast MR. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol. 2007;34(3):223-9.
Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012;2(6):241-54.
Shahrokhi A, Hassanzadeh G, Vousooghi N, Joghataei MT, Eftekhari S, Zarrindast MR. The effect of tiagabine on physical development and neurological reflexes and their relationship with the gamma-aminobutyric acid switch in the rat cerebral cortex during developmental stages. Behav Pharmacol. 2013;24(7):561-8.
Azizbeigi R, Zarrindast MR, Ahmadi S. Interaction between gamma-aminobutyric acid type A (GABAA) receptor agents and scopolamine in the nucleus accumbens on impairment of inhibitory avoidance memory performance in rat. Behav Brain Res. 2013;241:191-7.
Padulo C, Delli Pizzi S, Bonanni L, Edden RA, Ferretti A, Marzoli D, et al. GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images. Neuroscience. 2016;333:114-22.
Sokolowska E, Hovatta I. Anxiety genetics - findings from cross-species genome-wide approaches. Biol Mood Anxiety Disord. 2013;3(1):9.
Salari AA, Bakhtiari A, Homberg JR. Activation of GABA-A receptors during postnatal brain development increases anxiety- and depression-related behaviors in a time- and dose-dependent manner in adult mice. Eur Neuropsychopharmacol. 2015;25(8):1260-74.
Delli Pizzi S, Padulo C, Brancucci A, Bubbico G, Edden RA, Ferretti A, et al. GABA content within the ventromedial prefrontal cortex is related to trait anxiety. Soc Cogn Affect Neurosci. 2016;11(5):758-66.
Nasehi M, Shirkhodaei A, Ebrahimi-Ghiri M, Zarrindast MR. Abolishment of fear memory-disruptive effects REM sleep deprivation by harmane. Biomed Pharmacother. 2019;109:1563-8.
Kendler KS, Thornton LM, Prescott CA. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry. 2001;158(4):587
- Abstract Viewed: 247 times
- PDF Downloaded: 439 times